The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new ...

Unveiling the Molecular Impact of Smoking on Lung Health. This illustration explores how smoke components in cigarette and ...

In a new webinar, industry experts explore how innovative technology and direct patient communication are transforming medication adherence in the UK.

Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory ...

New evidence has linked PM1 pollution to significant increases in hospitalizations for COPD and pneumonia, with older adults ...

Sanofi (SYN) 43rd Annual J.P. Morgan Healthcare January 14, 2025 12:45 PM ETCompany ParticipantsPaul Hudson - Chief Executive OfficerFrancois-Xavier Roger ...

The health department on January 10 issued orders to all medical officers and civic hospitals to start surveillance and ...